Yang Ling Mai Di Sen Pharmaceutical Co., Ltd.
Yang Ling Mai Di Sen Pharmaceutical Co., Ltd., commonly referred to as Mai Di Sen, is a prominent player in the pharmaceutical industry, headquartered in China (CN). Established in the early 2000s, the company has made significant strides in the development and production of high-quality pharmaceutical products, primarily focusing on traditional Chinese medicine and modern therapeutics. With a strong operational presence across various regions in China and expanding internationally, Mai Di Sen is renowned for its innovative formulations and commitment to quality. The company’s core offerings include herbal extracts, dietary supplements, and prescription medications, distinguished by their efficacy and adherence to stringent safety standards. Recognised for its contributions to healthcare, Yang Ling Mai Di Sen has achieved notable market positioning, earning accolades for its research and development initiatives. As a trusted name in the pharmaceutical sector, the company continues to advance its mission of enhancing health and well-being globally.
DitchCarbon Score
How does Yang Ling Mai Di Sen Pharmaceutical Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Yang Ling Mai Di Sen Pharmaceutical Co., Ltd.'s score of 0 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Yang Ling Mai Di Sen Pharmaceutical Co., Ltd.'s reported carbon emissions
Yang Ling Mai Di Sen Pharmaceutical Co., Ltd., headquartered in CN, currently does not have available carbon emissions data for recent years, nor does it specify any reduction targets or climate pledges. As a result, the company's climate commitments and initiatives remain unclear. In the pharmaceutical industry, companies are increasingly focusing on sustainability and reducing their carbon footprints, but without specific data or commitments from Yang Ling Mai Di Sen, it is difficult to assess their position in this context.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Yang Ling Mai Di Sen Pharmaceutical Co., Ltd. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
